2 news · updated 5 days ago

Dr Reddy's API delay

2026-09-17

Dr Reddy's signs India distribution deal for Takeda's Qdenga dengue vaccine

Dr Reddy's Laboratories signed a distribution deal with Takeda for the Qdenga dengue vaccine in India, which was recently approved for use in children and adults. The vaccine is scheduled to become av

reuters · 2026-09-17 20:41 UTC

2026-07-08

Dr Reddy's delays semaglutide supply due to active ingredient issue

Dr Reddy's Laboratories delayed supplies of its semaglutide injection due to active ingredient specification issues, causing a 1.8% share price drop. The company confirmed no impact on patient safety

reuters · 2026-07-08 21:54 UTC

Dr Reddy's API delay

Dr Reddy's signs India distribution deal for Takeda's Qdenga dengue vaccine

Dr Reddy's delays semaglutide supply due to active ingredient issue

Media coverage (2)

Related topics